AstraZeneca PLC
1462.00
22-November-24 11:29:38
15 minutes delayed
Stocks
+48.50
+3.43%
Today's range
1419.00 - 1471.50
ISIN
N/A
Source
NASD.OMX SE
-
AstraZeneca Looks To China For Growth - But CEO Says Spinoff Not Happening
26 Sep 2023 08:07:47 By Forbes - Markets
-
AstraZeneca Looks To China For Growth - But CEO Says Spinoff Not Happening
26 Sep 2023 08:02:57 By Forbes - World
-
22 Sep 2023 05:43:29 By MarketWatch
-
AstraZeneca Reports Positive Results From Phase III Trial With Datopotamab Deruxtecan
22 Sep 2023 02:59:00 By NASDAQ US Markets
-
AZN : Phase III Trial Of FASENRA In Eosinophilic Granulomatosis With Polyangiitis Meets Main Goal
11 Sep 2023 23:09:20 By NASDAQ US Markets
-
AstraZeneca's Tagrisso Plus Chemotherapy Extended Median PFS In EGFR-mutated Advanced Lung Cancer
11 Sep 2023 04:44:24 By NASDAQ US Markets
-
AstraZeneca: FDA Issues CRL Regarding SBLA Of Ultomiris In NMOSD
06 Sep 2023 03:02:17 By NASDAQ US Markets
-
AstraZeneca's Calquence Approved In China For Chronic Lymphocytic Leukaemia
04 Sep 2023 03:53:41 By NASDAQ US Markets
-
AZN October 6th Options Begin Trading
24 Aug 2023 12:27:14 By NASDAQ Stocks
-
AstraZeneca Announces Approval Of Soliris In Japan For Expanded Use
24 Aug 2023 03:30:40 By NASDAQ US Markets